In an 85-year-old woman with elevated intact parathyroid hormone (110.6 pg/mL), hypercalcemia (serum calcium 11 mg/dL), and a cystic‑solid mass in the right thyroid lobe, what is the appropriate diagnostic work‑up and management?

Diagnostic Work-Up and Management

This 85-year-old woman has biochemically confirmed primary hyperparathyroidism (PTH 110.6 pg/mL with calcium 11 mg/dL), and the right thyroid mass is most likely an intrathyroidal parathyroid adenoma—though parathyroid carcinoma must be excluded given the moderately elevated PTH and her age.

Immediate Diagnostic Steps

Confirm Primary Hyperparathyroidism

The diagnosis is already established biochemically: hypercalcemia (11 mg/dL) with inappropriately elevated PTH (110.6 pg/mL) confirms primary hyperparathyroidism 1. Check 24-hour urinary calcium excretion to calculate fractional excretion and confirm the diagnosis is complete 1.

Localization Imaging

• Obtain Tc-99m sestamibi (MIBI) scan immediately 2. This is the standard first-line localization study for parathyroid adenomas, though cystic parathyroid lesions may show false-negative results 3, 4, 5.
• High-quality neck ultrasound is essential and should specifically evaluate the relationship between the thyroid mass and potential parathyroid tissue 2.

Critical Distinction: Adenoma vs. Carcinoma

The moderately elevated PTH (110.6 pg/mL) and presence of a cystic-solid mass raise concern for parathyroid carcinoma, which accounts for <1% of primary hyperparathyroidism but presents with severe hypercalcemia and markedly elevated PTH 2, 3. However, PTH levels >192 pmol/L (~1,800 pg/mL) are more typical of carcinoma 3. Giant cystic parathyroid adenomas can also present with high PTH levels mimicking carcinoma 6.

Specific Diagnostic Maneuvers

Aspiration of Cystic Component

Consider ultrasound-guided fine-needle aspiration of the cystic portion with PTH assay of the fluid 3, 5. Cystic fluid PTH levels are dramatically elevated (>1,000 pmol/L or >19 million pg/mL in reported cases) in functional parathyroid cysts 3, 7. This can confirm parathyroid origin when imaging is equivocal.

Pitfall: Standard cytology may be non-diagnostic and mistakenly attributed to thyroid pathology 5. Always request PTH assay on cystic fluid.

Additional Imaging if MIBI is Negative

If sestamibi is negative (common with cystic lesions 4, 5):

• Four-dimensional CT or MRI neck can better delineate the mass and its relationship to surrounding structures 2
• Consider selective venous sampling for PTH if localization remains unclear 7

Surgical Management

Operative Planning

This patient requires surgery given symptomatic hypercalcemia and confirmed primary hyperparathyroidism 2, 1. At age 85, surgery is still indicated as long-term hypercalcemia causes significant morbidity.

Surgical Approach

• If preoperative imaging localizes to the right thyroid mass: Perform right hemithyroidectomy with en bloc parathyroid resection 3, 8, 6
• Intraoperative PTH monitoring is mandatory: Expect >50% decline from baseline within 10-15 minutes of excision (Miami criterion) 3, 6
• If IOPTH does not fall appropriately: Explore for additional hyperfunctioning parathyroid tissue, including contralateral neck 3

Surgical Considerations for Carcinoma

If intraoperative findings suggest carcinoma (firm, adherent mass, local invasion):

• En bloc resection with ipsilateral thyroid lobectomy 8, 6
• Avoid tumor rupture to prevent seeding 8
• Central lymph node dissection if nodes appear involved 6

Do not perform frozen section as it may cause tumor spillage; proceed with en bloc resection and await final pathology 8.

Histopathological Confirmation

Final diagnosis requires:

• PTH immunohistochemistry (positive in parathyroid tissue) 8
• Thyroglobulin staining (negative in parathyroid tissue) 8
• Assessment for capsular/vascular invasion (indicates carcinoma) 8, 6, 9
• Galectin-3 and parafibromin staining if carcinoma suspected 9

Post-Operative Management

• Monitor calcium and PTH levels immediately post-op and at 6 months 2
• Expect hungry bone syndrome requiring calcium supplementation, especially given age and likely chronic hypercalcemia 4
• If parathyroid carcinoma confirmed: Lifelong surveillance with calcium, PTH, and neck ultrasound every 6-12 months 8

Key Clinical Pitfalls

1. Assuming the thyroid mass is thyroid pathology: Intrathyroidal parathyroid adenomas/carcinomas are rare but well-documented 3, 8
2. Relying solely on negative MIBI scan: Cystic parathyroid lesions frequently show false-negative sestamibi 4, 5
3. Inadequate IOPTH monitoring: Failure to achieve >50% PTH decline indicates incomplete resection 3
4. Underestimating surgical risk in elderly: While age 85 requires careful perioperative optimization, untreated hyperparathyroidism causes progressive bone disease, fractures, renal impairment, and neurocognitive decline—surgery improves quality of life and mortality 2, 1